150 related articles for article (PubMed ID: 33573542)
21. Synthesis and in vitro evaluation of new ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide against Entamoeba histolytica.
Duque-Montaño BE; Gómez-Caro LC; Sanchez-Sanchez M; Monge A; Hernández-Baltazar E; Rivera G; Torres-Angeles O
Bioorg Med Chem; 2013 Aug; 21(15):4550-8. PubMed ID: 23787289
[TBL] [Abstract][Full Text] [Related]
22. New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents.
Torres E; Moreno E; Ancizu S; Barea C; Galiano S; Aldana I; Monge A; Pérez-Silanes S
Bioorg Med Chem Lett; 2011 Jun; 21(12):3699-703. PubMed ID: 21570839
[TBL] [Abstract][Full Text] [Related]
23. Studies on log Po/w of quinoxaline di-N-oxides: a comparison of RP-HPLC experimental and predictive approaches.
Moreno E; Gabano E; Torres E; Platts JA; Ravera M; Aldana I; Monge A; Pérez-Silanes S
Molecules; 2011 Sep; 16(9):7893-908. PubMed ID: 22143549
[TBL] [Abstract][Full Text] [Related]
24. Isopropyl quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives induce regulated necrosis-like cell death on Leishmania (Leishmania) mexicana.
Chacón-Vargas KF; Andrade-Ochoa S; Nogueda-Torres B; Juárez-Ramírez DC; Lara-Ramírez EE; Mondragón-Flores R; Monge A; Rivera G; Sánchez-Torres LE
Parasitol Res; 2018 Jan; 117(1):45-58. PubMed ID: 29159705
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides.
Monge A; Palop JA; López de Ceráin A; Senador V; Martínez-Crespo FJ; Sainz Y; Narro S; García E; de Miguel C; González M
J Med Chem; 1995 May; 38(10):1786-92. PubMed ID: 7752202
[TBL] [Abstract][Full Text] [Related]
26. In vitro antimicrobial activities of animal-used quinoxaline 1,4-di-N-oxides against mycobacteria, mycoplasma and fungi.
Zhao Y; Cheng G; Hao H; Pan Y; Liu Z; Dai M; Yuan Z
BMC Vet Res; 2016 Sep; 12(1):186. PubMed ID: 27600955
[TBL] [Abstract][Full Text] [Related]
27. Molecular docking and dynamic simulations of quinoxaline 1,4-di-N-oxide as inhibitors for targets from Trypanosoma cruzi, Trichomonas vaginalis, and Fasciola hepatica.
González-González A; Méndez-Álvarez D; Vázquez-Jiménez LK; Delgado-Maldonado T; Ortiz-Pérez E; Paz-González AD; Bandyopadhyay D; Rivera G
J Mol Model; 2023 May; 29(6):180. PubMed ID: 37195391
[TBL] [Abstract][Full Text] [Related]
28. Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.
Ortega MA; Montoya ME; Jaso A; Zarranz B; Tirapu I; Aldana I; Monge A
Pharmazie; 2001 Mar; 56(3):205-7. PubMed ID: 11265583
[TBL] [Abstract][Full Text] [Related]
29. Esters of quinoxaline-7-carboxylate-1,4-di-
Palos I; Moo-Puc R; Vique-Sánchez JL; Benítez-Cardoza CG; Monge A; Villalobos-Rocha JC; Paz-Gonzalez AD; Rivera G
Acta Pharm; 2021 Sep; 71(3):485-495. PubMed ID: 36654088
[TBL] [Abstract][Full Text] [Related]
30. Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.
Ancizu S; Moreno E; Torres E; Burguete A; Pérez-Silanes S; Benítez D; Villar R; Solano B; Marín A; Aldana I; Cerecetto H; González M; Monge A
Molecules; 2009 Jun; 14(6):2256-72. PubMed ID: 19553897
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.
Jaso A; Zarranz B; Aldana I; Monge A
Eur J Med Chem; 2003 Sep; 38(9):791-800. PubMed ID: 14561478
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of quinoxaline di-N-oxide derivatives with in vitro trypanocidal activity.
Pérez-Silanes S; Torres E; Arbillaga L; Varela J; Cerecetto H; González M; Azqueta A; Moreno-Viguri E
Bioorg Med Chem Lett; 2016 Feb; 26(3):903-906. PubMed ID: 26750255
[TBL] [Abstract][Full Text] [Related]
33. Quinoxaline-1,4-dioxide derivatives inhibitory action in melanoma and brain tumor cells.
Silva L; Coelho P; Soares R; Prudêncio C; Vieira M
Future Med Chem; 2019 Apr; 11(7):645-657. PubMed ID: 30964331
[No Abstract] [Full Text] [Related]
34. Analysis of the effect of methyl 2-acetamide-3-methylquinoxaline-7-carboxylate 1,4-di-N-oxide on the relative expression of the trypanothione reductase gene in Trypanosoma cruzi epimastigotes.
Vazquez-Jimenez LKK; Hernandez-Posada MI; Paz-Gonzalez AD; Nogueda-Torres B; Martinez-Vazquez AV; Herrera-Mayorga V; Bocanegra-Garcia V; Rivera GR
Pak J Pharm Sci; 2019 May; 32(3 Special):1447-1452. PubMed ID: 31551230
[TBL] [Abstract][Full Text] [Related]
35. Ester of Quinoxaline-7-carboxylate 1,4-di-N-oxide as Apoptosis Inductors in K-562 Cell Line: An in vitro, QSAR and DFT Study.
Rivera G; Andrade-Ochoa S; Romero MSO; Palos I; Monge A; Sanchez-Torres LE
Anticancer Agents Med Chem; 2017; 17(5):682-691. PubMed ID: 27396382
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, biological evaluation and structure-activity relationships of new quinoxaline derivatives as anti-Plasmodium falciparum agents.
Gil A; Pabón A; Galiano S; Burguete A; Pérez-Silanes S; Deharo E; Monge A; Aldana I
Molecules; 2014 Feb; 19(2):2166-80. PubMed ID: 24552985
[TBL] [Abstract][Full Text] [Related]
37. New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis.
Sainz Y; Montoya ME; Martínez-Crespo FJ; Ortega MA; López de Ceráin A; Monge A
Arzneimittelforschung; 1999 Jan; 49(1):55-9. PubMed ID: 10028381
[TBL] [Abstract][Full Text] [Related]
38. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
[TBL] [Abstract][Full Text] [Related]
39. Quinoxaline 1,4-di-N-oxide and the potential for treating tuberculosis.
Vicente E; Villar R; Pérez-Silanes S; Aldana I; Goldman RC; Mong A
Infect Disord Drug Targets; 2011 Apr; 11(2):196-204. PubMed ID: 21470099
[TBL] [Abstract][Full Text] [Related]
40. Discovery of novel nitrogenous heterocyclic-containing quinoxaline-1,4-di-N-oxides as potent activator of autophagy in M.tb-infected macrophages.
Zhang H; Lu Q; Zhang J; Qu W; Xie S; Huang L; Yuan Z; Pan Y
Eur J Med Chem; 2021 Nov; 223():113657. PubMed ID: 34217060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
